You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK –Laboratory Corporation of America said Wednesday that its Covance drug development unit will join the Tempus TIME Trial program to accelerate patient enrollment for oncology clinical trials.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.